A UK High Court upheld a ban on prescribing puberty blockers to children, ruling the government was justified in prioritizing safety over potential benefits. The decision followed a review by Dr. Hilary Cass which indicated significant risks associated with the treatment. Campaigners from TransActual argued the ban was unlawful and harmful to young trans people, but the judge emphasized the need for evidence-based healthcare. This ruling has garnered mixed reactions, including support from Elon Musk, who labeled it 'common sense.' Meanwhile, a government-commissioned review dismissed claims that restricting access to these treatments increases suicide risks among trans youth, stating that available data did not support such assertions. The ongoing debate reflects deep societal divisions over gender identity and healthcare for minors.